Signify Health, Inc.
Signify Health, Inc. Fundamental Analysis
Signify Health, Inc. (SGFY) shows weak financial fundamentals with a PE ratio of -41.22, profit margin of -16.19%, and ROE of -14.90%. The company generates $1.3B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -5.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze SGFY's fundamental strength across five key dimensions:
Efficiency Score
WeakSGFY struggles to generate sufficient returns from assets.
Valuation Score
ExcellentSGFY trades at attractive valuation levels.
Growth Score
ModerateSGFY shows steady but slowing expansion.
Financial Health Score
ExcellentSGFY maintains a strong and stable balance sheet.
Profitability Score
WeakSGFY struggles to sustain strong margins.
Key Financial Metrics
Is SGFY Expensive or Cheap?
P/E Ratio
SGFY trades at -41.22 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, SGFY's PEG of -0.41 indicates potential undervaluation.
Price to Book
The market values Signify Health, Inc. at 8.57 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -326.26 times EBITDA. This is generally considered low.
How Well Does SGFY Make Money?
Net Profit Margin
For every $100 in sales, Signify Health, Inc. keeps $-16.19 as profit after all expenses.
Operating Margin
Core operations generate 13.53 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-14.90 in profit for every $100 of shareholder equity.
ROA
Signify Health, Inc. generates $-7.48 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Signify Health, Inc. produces operating cash flow of $162.87M, showing steady but balanced cash generation.
Free Cash Flow
Signify Health, Inc. produces free cash flow of $115.84M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.40 in free cash annually.
FCF Yield
SGFY converts 0.78% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-41.22
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.41
vs 25 benchmark
P/B Ratio
Price to book value ratio
8.57
vs 25 benchmark
P/S Ratio
Price to sales ratio
11.09
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.58
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.62
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.15
vs 25 benchmark
ROA
Return on assets percentage
-0.07
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How SGFY Stacks Against Its Sector Peers
| Metric | SGFY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -41.22 | 29.43 | Better (Cheaper) |
| ROE | -14.90% | 800.00% | Weak |
| Net Margin | -16.19% | -20145.00% (disorted) | Weak |
| Debt/Equity | 0.58 | 0.30 | Weak (High Leverage) |
| Current Ratio | 1.62 | 4.64 | Neutral |
| ROA | -7.48% | -17936.00% (disorted) | Weak |
SGFY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Signify Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation